Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 189.34M P/E - EPS this Y -44.40% Ern Qtrly Grth -
Income -18.71M Forward P/E -11.89 EPS next Y 10.30% 50D Avg Chg -12.00%
Sales 52.35M PEG -0.12 EPS past 5Y -26.87% 200D Avg Chg 43.00%
Dividend N/A Price/Book 5.25 EPS next 5Y 15.00% 52W High Chg -51.00%
Recommedations 2.20 Quick Ratio 4.54 Shares Outstanding 34.64M 52W Low Chg 318.00%
Insider Own 17.92% ROA -18.80% Shares Float 24.98M Beta 1.13
Inst Own 47.99% ROE -58.26% Shares Shorted/Prior 371.13K/1.57M Price 5.47
Gross Margin 64.49% Profit Margin -35.75% Avg. Volume 330,887 Target Price 3.63
Oper. Margin -39.39% Earnings Date May 9 Volume 144,705 Change -1.08%
About Apyx Medical Corporation

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Apyx Medical Corporation News
04/25/24 Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
04/11/24 Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
03/26/24 Downgrade: Here's How Analysts See Apyx Medical Corporation (NASDAQ:APYX) Performing In The Near Term
03/23/24 Apyx Medical Corporation (NASDAQ:APYX) Just Reported And Analysts Have Been Cutting Their Estimates
03/22/24 Apyx Medical Corporation (NASDAQ:APYX) Q4 2023 Earnings Call Transcript
03/22/24 Further weakness as Apyx Medical (NASDAQ:APYX) drops 22% this week, taking three-year losses to 87%
03/21/24 Q4 2023 Apyx Medical Corp Earnings Call
03/21/24 Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates
03/21/24 Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
07:30 AM Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
02/21/24 Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting
02/08/24 Favourable Signals For Apyx Medical: Numerous Insiders Acquired Stock
01/22/24 Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body
01/08/24 Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results
11/28/23 Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer
11/10/23 Apyx Medical Corporation (NASDAQ:APYX) Q3 2023 Earnings Call Transcript
11/09/23 Apyx Medical Corp (APYX) Reports 31% Revenue Growth in Q3; Updates Full Year Outlook
11/09/23 Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors
11/09/23 Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook
11/07/23 Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November
APYX Chatroom

User Image Stock_Titan Posted - 04/25/24

$APYX Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024 https://www.stocktitan.net/news/APYX/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-c6e2msj4ky44.html

User Image IsabellaDC Posted - 04/23/24

Thinly traded scan: $CODA $LGIO $GBIO $JFU $APYX and so on.

User Image Stock_Titan Posted - 04/11/24

$APYX Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit https://www.stocktitan.net/news/APYX/apyx-medical-corporation-showcases-new-data-and-treatment-insights-uln74p5wc1p1.html

User Image Fullratio Posted - 03/22/24

$APYX EV/Sales is 87% lower than its 5-year quarterly average of 5.7 and 67% lower than its last 4 quarters average of 2.3: https://fullratio.com/stocks/nasdaq-apyx/apyx-medical

User Image Capes Posted - 03/21/24

$OVID $APYX $NXL $XELA $IDN

User Image OpenOutcrier Posted - 03/21/24

$APYX (-16.8% pre) Apyx: Q4 Earnings Snapshot - AP https://ooc.bz/l/28347

User Image DonCorleone77 Posted - 03/21/24

$APYX Apyx Medical sees FY24 revenue $ $49.7M-$52.9M, consensus $59.76M Net loss attributable to stockholders of approximately $26.5 M to $24.3M, compared to $18.7M for the year ended December 31.

User Image epsguid Posted - 03/21/24

$APYX reported a loss of $0.19, consensus was ($0.13) via @eWhispers #epsmiss http://eps.sh/d/apyx

User Image Stock_Titan Posted - 03/21/24

$APYX Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook https://www.stocktitan.net/news/APYX/apyx-medical-corporation-reports-fourth-quarter-and-full-year-2023-veqnw9j001xf.html

User Image stklover Posted - 03/12/24

$APYX For anyone who has interest in this stock (not many on this site), wondering if this might be an opportunity here under $1.70? Thanks

User Image Stock_Titan Posted - 2 months ago

$APYX Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024 https://www.stocktitan.net/news/APYX/apyx-medical-corporation-to-release-fourth-quarter-and-fiscal-year-sjk3cb9s9a2i.html

User Image TickerDD_com Posted - 02/21/24

From 2/16/2024, looking back across 22 Month-Ends for APYX, Percentage Change of Average Monthly Price had More Positives (59%) while Percentage Change of Average Monthly Volume had All Positives (100%) $APYX #APYX #APYXStock #TickerDD #APYXPrice https://www.youtube.com/watch?v=Ug7Y0UbHywM

User Image Stock_Titan Posted - 02/21/24

$APYX Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting https://www.stocktitan.net/news/APYX/apyx-medical-corporation-announces-renuvion-to-be-featured-in-u0gt9nfi571a.html

User Image Toyaga Posted - 02/09/24

$APYX Another stoploss raids through dark pool money with the hope of getting phat before the stock rockets up.

User Image Toyaga Posted - 02/07/24

$APYX These stoploss raids are always welcome :)

User Image VirmoMopire Posted - 01/30/24

$APYX Just spotted some interesting activity on this one. 🧐

User Image tickeron Posted - 01/24/24

What do you think of this? $APYX Stochastic Oscillator left the oversold zone. View odds of downtrend. https://srnk.us/go/4977750

User Image cctranscripts Posted - 01/23/24

Royce & Associates, LP just provided an update on share ownership of Bovie Medical Corporation https://www.conferencecalltranscripts.org/summary/?id=12886517 $BVX

User Image cctranscripts Posted - 01/23/24

Royce & Associates, LP just provided an update on share ownership of Bovie Medical Corporation https://www.conferencecalltranscripts.org/summary/?id=12886509 $BVX

User Image STCKPRO Posted - 01/23/24

$APYX NEW ARTICLE : Apyx stock rises on publication of Renuvion safety analysis https://stck.pro/news/APYX/73502783/

User Image STCKPRO Posted - 01/23/24

$APYX NEW ARTICLE : Craig-Hallum Gives a Buy Rating to Apyx Medical (APYX) https://stck.pro/news/APYX/73496520/

User Image STCKPRO Posted - 01/22/24

$APYX NEW ARTICLE : Lake Street Keeps Their Buy Rating on Apyx Medical (APYX) https://stck.pro/news/APYX/73496450/

User Image STCKPRO Posted - 01/22/24

$APYX NEW ARTICLE : Analysts Offer Insights on Healthcare Companies: Ufp Technologies (UFPT), Apyx Medical (APYX) and Wuxi Biologics (Cayman) (OtherWXIBF) https://stck.pro/news/APYX/73488443/

User Image Aeriya Posted - 01/22/24

$APYX The authors noted that there are currently no alternative therapies to Renuvion cleared by the U.S. Food and Drug Administration (“FDA”) which can claim use following liposuction for the purpose of contracting the subcutaneous soft tissue.

User Image Aeriya Posted - 01/22/24

$APYX “We are excited to see the publication of this real-world 483-patient analysis, demonstrating Renuvion’s impressive safety when used after liposuction, which is now the most commonly performed cosmetic procedure in the world."

User Image STCKPRO Posted - 01/22/24

$APYX NEW ARTICLE : Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body https://stck.pro/news/APYX/73465536/

User Image tickeron Posted - 01/22/24

A.I.dvisor made a bearish call on $APYX, netting in a 21.12% gain over 3 weeks https://srnk.us/go/4975947

User Image cctranscripts Posted - 01/22/24

Bovie Medical: Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication https://www.conferencecalltranscripts.org/summary/?id=12882657 $BVX

User Image Last10K Posted - 01/22/24

$APYX just filed with the SEC a Financial Exhibit https://last10k.com/sec-filings/APYX/0000719135-24-000005.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=APYX

User Image risenhoover Posted - 01/22/24

$APYX / Apyx Medical files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 January 22, 2024 Date of Report (date of earliest event reported) APYX MEDICAL CORP https://fintel.io/doc/sec-apyx-medical-corp-719135-8k-2024-january-22-19744-3048?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

Analyst Ratings
Stephens & Co. Overweight Nov 10, 23
Piper Sandler Overweight Aug 11, 23
Stephens & Co. Overweight Jul 14, 23
Lake Street Buy Jun 15, 23
JMP Securities Market Perform May 24, 23
Lake Street Buy May 12, 23
Piper Sandler Overweight Aug 12, 22
Lake Street Buy Jul 19, 22
Lake Street Buy May 20, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
HILL MATTHEW C Chief Financial Offi.. Chief Financial Officer Dec 12 Buy 2.19 2,500 5,475 2,500 12/14/23
Geraghty Michael Director Director Jun 06 Option 2.79 10,000 27,900 27,500 06/09/23
Goodwin Charles D. II Chief Executive Offi.. Chief Executive Officer Aug 29 Buy 5.95 11,750 69,912 40,000 08/31/22
CITRONOWICZ MOSHE Sr. V.P. of Operatio.. Sr. V.P. of Operations Jul 11 Option 2.54 30,000 76,200 456,504 07/12/22
Waldman Lawrence Director Director Jul 11 Option 2.54 24,000 60,960 37,563 07/11/22
Geraghty Michael Director Director Jul 06 Option 2.54 4,000 10,160 17,500 07/11/22
Waldman Lawrence Director Director May 19 Option 2.79 8,000 22,320 13,563 05/23/22
Geraghty Michael Director Director May 11 Option 2.79 6,000 16,740 13,500 05/19/22
Swandal Craig A. Director Director Mar 21 Option 4.98 17,000 84,660 17,000 03/22/22